Employing the myeloblastic leukemia M1 cell line, which does not express endogenous 4153, and genetically engineered variants, it was recently shown that activation of p53, using a p53 temperature-sensitive mutant transgene (p53ts). resulted in rapid apoptosis that was delayed by high level ectopic expression of bcl-2. In this report, advantage has been taken of these M1 variants t o investigate the relationship between p53-mediated G1 arrest and apoptosis. Flow cytometric cell cycle analysis has provided evidence that activation of wild-type ( w t ) p53 function in M1 cells resulted in the induction of G1 growth arrest; this was clearly seen in the Mlp53/bcl-2 cells because of the delay in apoptosis that unmasked p53-induced G1 growth arrest. This finding was further corroborated at the molecular level by analysis of the expression and function of key cell cycle regulatory genes in Mlp53 versus Mlp53/bcl-2 cells after the activation of wt p53 function; events that take place at early times during the p53-induced G1 arrest occur in both PROFOUND EXAMPLE of cell homeostasis that is regulated throughout life is the complex process of blood cell formation. This process requires the participation of many factors, including positive and negative regulators of growth and differentiation, which determine survival, growth stimulation, differentiation, functional activation, and programmed cell death (apoptosis). Consequently, any alterations in these pathways could contribute to leukemogenesis.' In addition to growth arrest and apoptosis being implicated in normal hematopoeisis, they have been shown to modulate the cellular response to DNA-damaging agents used as anticancer agents.' It is, therefore, of primary importance to understand how the growth arrest and apoptosis mechanisms are regulated and to discern the molecular players involved in these mechanisms.
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The tumor-suppressor gene p53 has become a major player in the context of studying the molecular biology of growth arrest and apoptosis and how aberrations in these pathways may contribute to tumorigenicity. Inactivation of p53 is a common event in the development of human malignancies, occumng in more than 50% of all tumor^.^ p53, a nuclear protein that binds to specific DNA sequences and functions as a transcriptional regulator," was observed to suppress cell growth' and in several cell types to induce apopto~is.~.~ Experimental evidence has accumulated to indicate that rndrn2,' g~d d 4 5 ,~
and Wufl" are important players in p53-mediated effects, and it has been shown that mdm2 and Wufl are direct target genes of p53',''; along similar lines, the proto-oncogene c-myc, implicated in the control of cell proliferation, was documented to be trans-repressed by p53." Recently, by activating wild-type p53 (wt p53) function of a temperature-sensitive p53 (p53'") transgene in M1 myeloblastic leukemia cells, which do not express endogenous p53, the spectrum of p53 target genes has been broadened to include bcl-2 and bar,'', 13 topic p53" andor bcl-2, it was observed that, after activation of wt p53 function, Mlp53 cells underwent rapid apoptosis, whereas Mlp53ibcl-2 cells underwent delayed apoptosis." In this report, advantage has been taken of these M1 cell variants to gain insight into the relationship between the genetic programs of p53-mediated growth arrest and p53-mediated apoptosis induced within the same cell type. It is shown that activation of wt p53 in M1 cells results in the simultaneous induction of the genetic programs of p53-mediated growth arrest and p53-mediated apoptosis. Rapid apoptosis prevents the cells from G1 arresting (as is the case in Mlp53 cells), whereas delaying the apoptotic response (ie, overexpression of bcl-2 in Mlp53ibcl-2) allows the cells to G1 arrest, showing that the genetic program of p53-induced cell death can proceed in either G1-arrested (Mlp53/ bcl-2) or cycling (Mlp53) cells.
MATERIALS AND METHODS
Cells and cell culture. The differentiation competent murine M I myeloid leukemic cell line (clone 6) and establishment of the Mlp53 (clone 7), Mlp53hcl-2 (clone 12), and Mlbcl-2 (clone S ) cell lines have been described previously," and the data presented were obtained using these clones. However, for each cell variant, three independent cell lines were examined,'' for which the results were similar to the data presented. Three
Mlneo control lines consistently behaved like the parental M1 cells. Cells were cultured in Dulbecco's modified Eagle's medium (GIBCO, Grand Island, NY) and 10% horse serum in a humidified atmosphere with 10% CO,. Cells were seeded at 0.15 X 106/mL at either 37.5"C or 32.5"C, as indicated. For RNA extractions, at early times after temperature shifts, cell concentrations were adjusted to give a final density of greater than 0.25 X IO6 cells/mL at the time of extraction.
Assays for apoptosis-associated properties. Recombinant DNA techniques, DNA probes, RNA extraction, and RNA blots. Plasmid preparations, restriction enzyme digestions, DNA fragment preparations, and agarose gel electrophoresis were as described before.'"'' Probe for gadd45 was a Kpn I-Sac I hamster cDNA fragment (1.2 kb) excised from pXR45m.IX Probe for mdm2 was the murine mdm2 cDNA insert (1.4 kb) of pl IB, a kind gift from Dr Donna George. Waf1 probe was a 440-bp murine fragment obtained by polymerase chain reaction (PCR) of RNA from Mlp53 cells shifted to 32.5"C for 3 hours. The oligo dT-primed reverse transcriptase (RT) reaction was performed using a GIBCO BRL Kit. The amplimers used for PCR amplification were 5"CCATGTCCA-ATCCTGGTGATGTCCG-3' and S'-TTTCGGCCCTGAGATGjT-CCGG-3'. PCR conditions were denaturing at 94°C for 5 minutes followed by 30 cycles at 94°C for I minute, 60°C for I minute, and 72°C for 2 minutes and extension at 72°C for 7 minutes. Identity of the PCR product was confirmed by direct sequencing. Relative levels of endogenous murine bcI-2 mRNA were measured using semiquantitative RT-PCR, analyzing PCR products by probing with hcl-2; to monitor for reproducibility of the PCR reaction, RT-PCR for p2-microglobulin (p2M) was performed. This analysis was performed as previously described." Probes for bax, c-myc, and p-actin were the same as used previously."." RNA was extracted by the method of Chomczynski and Sacchi, using guanidinium thiocyanate, as previously described." Total RNA (10 pgllane) was electrophoresed on I% agarose formaldehyde gels. Northern blots, using Duralon-UV membranes (Stratagene, La Jolla, CA), were prepared and UV cross-linked (Stratalinker; Stratagene) before baking. Hybridization and washing conditions and stripping blots of probe to rehybridize were performed as described previously.'y Equal amounts of RNA in each lane was confirmed by equal intensity of ethidium bromide staining of ribosomal RNA bands and hybridization with a p-actin probe.
Immunoprecipitations, immunoblotting, und kinase a.ssuy.s.
Immunoprecipitations were performed as described by Grafia et dium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) were transferred to immobilon (Millipore, Boston. MA) in IO nnnol/L CAPS/IO% methanol buffer (pH 11) and detected with horseradish peroxidase and enhanced chemiluminescence (ECL; Amersham, Arlington Heights, IL). Kinase assays were performed as described." Briefly, immunoprecipitated complexes were incubated at 30°C for 20 to 30 minutes in 20 m m o l k HEPES, 10 mmol/ L magnesium acetate, I mmol/L DTT, 20 pmol/L ATP, 2.2 X 10' cpdpmol of y-"P-ATP (Dupont, Wilmington, DE), and 2.5 pg of histone HI (Boehringer Mannheim, Indianapolis, IN) in a total volume of 25 pL. The reaction was terminated by the addition of 25 pL of 2 X Laemmli sample buffer, and the labeled proteins were resolved by SDS-PAGE. An equal amount of protein was used in all assays; protein determinations were performed using the BioRad protein assay (Hercules, CA). Preparation of specific anti-C-terminal peptide antibodies to cdc2 (G6) and cdk2 have been described.'"
Polyclonal anti-cyclin E was a kind gift of J. Roberts and E. Firpo To better understand the effects of p53 and Bcl-2, separately and in combination, on M1 cell growth and viability, we determined the viable cell number of parental MI cells and the genetically engineered MI variants, including MlpS3, Mlbcl-2, and MlpS3/bcl-2 cells, at different times after culturing of the cells at 37.S"C and at 32.S°C, the permissive temperature for activation of wt function of the p53" transgene (Fig l) . As shown in Fig IA, for all of these cell lines the number of viable cells increased similarly at 37.5"C. At the permissive temperature (32.S°C), the number of viable cells for M1 and Mlbcl-2 continued to increase and the percentage of living cells remained constant up to 4 days in culture (Fig 1A and B) . In contrast, at 32.S"C MlpS3 cells exhibited a decrease in viable cell number, which was associated with a rapid loss in the percentage of living cells ( Fig  1C) because of apoptotic cell death (as evident from cell morphology and the appearance of a DNA ladder"). Unlike the MlpS3 cells, at 32.S"C the number of viable MlpS3hcl-2 cells increased up to 1 day and decreased marginally by the second day (Fig IB) , with a significant decrease in the percentage of living cells observed only after 1 day (Fig  1 C) .
Taken together, these observations indicate that ( I ) ectopic expression of bcl-2 had no significant effect on the growth and viability of M1 cells, (2) activation of wt p53 function resulted in a rapid loss of MI cell viability, and (3) ectopic expression of bcl-2 in combination with wt p53 function delayed this rapid loss in cell viability, with the number of MlpS3hcl-2 cells not increasing beyond day 1. For personal use only. on November 16, 2017 . by guest www.bloodjournal.org From second day after activation of wt p53 function may reflect p53-induced growth arrest or, alternatively, an equilibrium between cell death and cell proliferation. To address this issue, M1 parental cells and the genetically engineered variants, expressing ectopic p53" andlor bcl-2, were subjected to flow cytometric analysis after incubation at 32.5"C, choosing an appropriate window in the FACS such that only living cells were included in the analysis.
As shown in Fig 2, for the M1 and Mlbcl-2 cell lines, neither the distribution of cells in the different phase of the cell cycle (GO/Gl; 53% 5 4%; S , 26% 2 4%; GUM, 21% 2 2%; Fig 2A) nor the GUS ratio (2 2 0.4; Fig 2B) varied significantly after shifting the cultures to 3 2 . W for various times. After 18 hours of incubation of the Mlp53 cells at 32S°C, a point in time when the majority of the cell population already had undergone apoptotic cell death (with only 20% viable cells), only a small increase was observed in the percentage of cells in the G1 phase of the cell cycle, from 60% up to 71%; in parallel, a decrease in the percentage of cells in the S phase, from 25% down to 14%, was observed (Fig 2A) . These alterations in distribution of cells in the different phases of the cell cycle resulted in a small increase in the GlfS ratio (up to 5.3; Fig 2B) . In sharp contrast, it can be seen that the percentage of Mlp53hl-2 cells in G1 increased to 80% by 24 hours (with 92% of the cells viable), to 87% by 48 hours (with 61% of the cells viable), and to 96% by 96 hours, which was the latest time point when there were still enough viable cells amenable for FACS analysis (Fig 2A) . Paralleling this impressive accumulation of Mlp53hcl-2 cells in the G1 phase of the cell cycle were the decreases observed in the percent of cells in the S and the G2/M phases (7% and 12% by 24 hours, respectively, with 92% of the cells viable), ultimately resulting in a GUS ratio of 32 (Fig 2B) . Based on these data, it can be concluded that the number of viable Mlp53hcl-2 cells is a reflection of an equilibrium between G1 growth arrest, proliferation, and cell death, and that between 1 and 2 days most of the cells have undergone G1 arrest.
Taken together, these observations clearly show that activation of wt p53 function in M1 myeloid precursor cells resulted in the induction of both G1 growth arrest and apoptosis. It is notable that the G1 growth arrest was clearly seen only in the Mlp53hcl-2 cells, because of ectopic bcl-2 expression that delayed apoptosis compared with that in Mlp53 cells, thereby unmasking p53-induced GI arrest. The subtle changes in cell cycle distribution observed in Mlp53/ bcl-2 cells up to 18 hours after activation of wt p53 function is very similar to what was observed for Mlp53, despite the fact that in the latter case only 20% of the cells were living; these data are consistent with the notion that cells undergoing p53-induced apoptosis do not select from a subpopulation of cells with regard to cell cycle status. This notion is corroborated by the fact that the ultimate fate of the M1 cells expressing wt p53 was apoptosis, showing that the p53-induced genetic program of apoptosis can proceed in either G1-arrested (Mlp53hcl-2) or cycling (Mlp53) cells.
Expression and function of cell cycle regulatory genes in Mlp53 versus Mlp53hl-2 cells after activation of wt p53 function. Progression through the cell cycle of dividing cells is governed by a family of protein kinases known as cyclin-dependent kinases (cdks) and their regulatory subunits, the cyclins. Activation of the cdks is regulated by association with the cyclins and by the phosphorylation state of both components of the complexes formed." The socalled GI cyclins (E and D), in particular the cyclin Ucdk2 complex, have been implicated in GI/S transition, whereas the cyclin A/cdk2 complex has been implicated in the progression of cells during S phase." One means by which cdks are known to exert positive growth control is by hyperphosphorylation and inactivation of negative cell cycle regulators, such as the retinoblastoma gene product (pRb). thereby overriding their ability to suppress GI exit." Therefore. it was of interest to determine the expression of these critical cell cycle regulators, their phosphorylated state. and the kinase activity of the complexes formed in the M I p53 and M 1 p531 bcl-2 cell lines. which were observed to undergo apoptosis and G1 arrest with distinct kinetics.
As shown in Fig 3A, no significant changes in the levels of cyclin A, E. and D1 proteins or in their cyclin-associated histone HI kinase activities were observed in the MI and M 1 bcl-2 cells harvested at various times in culture at 32.S"C. Also, there was no detectable change in the level of cyclin D1 protein in MlpS3 and MlpS3/bcl-2 cells at 32.S°C, the permissive temperature for activation of wt p53 function. In contrast. the levels of cyclin A protein and cyclin A-associated kinase activity decreased both in MlpS3 and M Ips31 bcl-2 cells after 12 and 24 hours, respectively, at 3 2 5°C with no detectable cyclin A protein and cyclin A-associated kinase activity in the MlpS3/bcl-2 cells by 48 hours. As for cyclin E. no change in the level of cyclin E protein and cyclin E-associated kinase activity was observed in the M Ips3 and M lpS3/bcI-2 cells after 18 hours of incubation at 32.S°C, whereas in the MIpWbcl-2 cells. by 48 hours the cyclin Eassociated kinase was inactive with no apparent change in the level of cyclin E protein. As shown in Fig 3B. no quantitative or qualitative changes in cdk2 and cdc2 proteins were observed in any of the 4 cell lines after 18 hours at 32.S"C: however. in MlpS3/bcl-2 the bands corresponding to the active forms were absent by 48 hours. Consistent with this finding was the observation that. in the MlpS3/bcl-2 cells. the cdk2 and cdc2-associated kinase activities were not detectable at the 48-hour time point. Finally. as shown in Fig  3C. mainly the hyperphosphorylated forms of pRb and a mix of different phosphorylation states of p107 were detected in exponentially growing MI and Mlbcl-2 cells at 32.S"C. In contrast. within 12 hours after placing the MlpS3 and M 1 pS3hcl-2 cells at 32.S"C. the protein band corresponding to the hyperphosphorylated form of pRb was observed to shift to faster SDS-PAGE gel migrating bands. representing the hypophosphorylated forms of pRb. As for p107. the shift from the hyperphosphorylated to the hypophosphorylated form occurred within 12 and 24 hours. respectively. after placing the MlpS3 and MlpS3/bcl-2 cells at 32.5"C.
In conclusion. the expression patterns. phosphorylated
For personal use only. on November 16, 2017 . by guest www.bloodjournal.org From state, and kinase activities that have been observed for these regulatory cell cycle elements provide further support for the notion that activation of wt p53 function in M1 myeloid precursors activates the genetic program associated with G l growth arrest, in addition to induction of cell death. Events that were observed to occur at early times during the p53-induced G1 arrest (ie, decrease in the expression and kinase activity of cyclin A and dephosphorylation of pRb and p107)
were detected in both the Mlp53 and the Mlp53hcl-2 cells, whereas later events (ie, inactivation of the kinase activities of cyclin E, cdk2, and cdc2) were seen only in the Mlp53/ bcl-2 cells. These observations are consistent with the rapid kinetics of apoptosis of the Mlp53 cells that prevent the cells from completing G1 arrest, as opposed to the delayed apoptotic kinetics of the Mlp53hcl-2 cells, which afford the cells sufficient time to G1 arrest before undergoing apoptosis, thereby unmasking p53-induced G1 arrest of the M1 cells.
Expression of genes implicated in p53-mediated growth arrest and apoptosis. The data presented thus far establish, both at the cellular and molecular level, that activation of wt p53 function in M1 cells initiates pathways for both G1 growth arrest and apoptosis. It was of obvious interest to examine the expression of genes that have been implicated in mediating the effects of p53 on growth and apoptosis (ie, gadd45, Wafl, mdm2, c-myc, bcl-2, and bux) in the M1 cell system after activation of wt p53 function. As shown in Fig 4A, the expression of gadd45 and Wafl mRNAs were undetectable in M1 and Mlbcl-2 cells incubated at either 32.5"C or 37.5"C, whereas mdm2 and bax mRNAs exhibited low basal levels of expression in these cells. After activation of wt p53 function at 32.5"C, similar kinetics of induction/ upregulation were observed for the mRNAs of gadd45, Wafl, and mdm2 in the Mlp53 and Mlp53hcl-2 cells. In addition, bax &A, which was upregulated in Mlp53, continued to increase in the Mlp53hcl-2 cells, which underwent delayed apoptosis compared with the Mlp53 cells (Figs 1C  and 4A ; compare Mlp53 at 18 hours with Mlp53hcl-2 at 48 hours). As seen in Fig 4B, endogenous bcl-2 and c-myc mRNAs were expressed at similar levels in M1 and Mlbcl-2 cells incubated at 32.5"C and in the Mlp53 and Mlp53/ bcl-2 cells were downregulated similarly after activation of wt p53 function at 32.5"C. St is notable that the kinetics of c-myc downregulation in the Mlp53 and Mlp53hcl-2 cells were exceptionally rapid, with no c-myc mRNA detectable by 6 hours; also notable is that the level of endogenous bcl-2 mRNA continued to decrease in the Mlp53hcl-2 cells compared with Mlp53 cells, which could be analyzed only up to 18 hours for RNA because of the rapid apoptotic response (Fig 1C) . These data show that a spectrum of p53 target genes implicated in p53-induced growth suppression and apoptosis are similarly regulated upon induction of wt p53 function in the MIp53 and Mlp53hcl-2 cells. Thc findings presented in this report lead to the conclusion that the outcome of p53 activation in a given cell type is dependent on its ability to induce G 1 arrest and/or apoptosis. as well a s the relative kinetics of these processes. This provides a tangible working hypothesis to understand the molecular mechanisms that underlie p53-mediated responses in different cell types. both in vitro and in vivo. For example. it is predicted that in cells in which genes involved only in the mediation of G I growth arrest are amenable to induction by wt pS3. activation of p53 function will result in GI growth Consistent with this notion are our recent observations that hn.r. unlike other p53 target genes (ie. gndd45 and WC!//) is an unique p53-regulatcd gene in that its induction by genotoxic stress requires not only functional p53 but also that the cells be apoptosis "proficient."'" In cells in which genes mediating both G 1 arrest and apoptosis are responsive to p53. p53 activation will result in the induction of both of these cellular processes: completion of G I arrest will depend on the time of apoptosis. as shown in this study. It is surprising that until now induction of pS3-mediated GI growth arrest and apoptosis were not documented to occur in a particular cell type as the result of the same stimulus. For example. introduction of p53 into fibroblast cell lines devoid of endogenous wt p53 was documented to result in only GI growth arre~t.".'~.'~.?~ Also. exposure of cells to DNA-damaging agents".'".'" highlighted p53 as a critical participant in the physiologic pathway that causes GI arrest of cells in response to genotoxic stresses. On the other hand. activation of wt p53 function of ectopically expressed pS3" mutant in growing populations of hematopoietic cells, which lack endogenous p53 expression.'.''.''.'' or in kidney cells transformed with E/A+pS3"." showed a role for wt p53 as an inducer of programmed cell death. Activation of wt p53 function in MI myeloblastic leukemia or in primary baby Fisher kidney (BRK) cells was shown to result in apoptosis in the absence of measurable GI growth arrest."." In murine erythroleukemia cells. activation of wt p53 function has lead to the conclusion that p53 induces cell death predominantly in the GI phase of actively cycling cells."
Given that inactivation of PS.? occurs in more than 50% of a l l tumors' and that p52 is required for induction of apoptotic cell death by y-radiation and chemotherapeutic dn~gs,".)~ the role downstream effectors of p53 may play in malignancy as well as in the response of tumors to radiation and chemotherapeutic drugs also must be considered when trying to decipher the molecular genetics of pS3. For example. in both the BRK and the murine erythroleukemia cells that were genetically engineered to express a p.53" mutant transgene and high levels of /x/-2. activation of wt p53 resulted in growth arrest that was leaky and. rather than occurring at G I phase as in M 1 p53hcP cells. occurred nonspecifically at multiple points in the cell cycle.".-'" Clearly, it will be of interest to determine to what extent alteration(s) in the expression or function of the genes that mediate p53-induced GI arrest may be responsible for the failure of these transformed cell types to arrest in GI. Intriguingly. p53-dependent apoptosis in the absence of transcription has been documented recently in cells that. before activation of wt p53 function, have been exposed to high levels of DNAdamage inducing agents (ie. UV-or y-radiati~n).'~
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We have recently shown that transforming growth factor P-1 (TGFP-l) induces growth arrest and apoptosis in M1 cells. '5,38 The novel differentiation primary response gene MyD118, whose amino-acid sequence and growth suppressive functions were observed to be closely related to those of g~d d 4 . 5 ,~~ was shown to be a TGFP-l-induced primary response gene that positively modulates TGFP-1-induced cell death." gadd45, a primary response gene to p53 (this report and unpublished data), was not induced by TGFP-1, and activation of wt p53 in M1 cells did not induce MyD118 (unpublished data). Thus, given the sequence similarities between gadd45 and MyDI18, a role for gadd4. 5, implicated in p53-induced G1 arrest, as a modulator of p53-induced apoptosis is possible.
In conclusion, in this work we have used genetically engineered variants of M1 hematopoietic precursor cells as a model system to molecularly dissect p53-induced G1 growth arrest and apoptosis. It has been shown, at the molecular and cellular level, that activation of wt p53 in M1 cells resulted in the induction of the genetic programs of both G1 growth arrest and apoptosis, and that when apoptosis was delayed by ectopic expression of bcl-2, G1 arrest was unmasked. The ability to induce M1 growth arrest and apoptosis by either p53 or TGFP-1, and the availability of the multitude of genetically engineered M1 variants, makes it possible to compare and contrast the apoptotic pathways induced by these two distinct stimuli using the same cells, allowing for further analysis of the roles played by differentiatiodgrowth arrest primary response genes, protooncogenes and tumor suppressor genes in the regulation of p.53-dependent and independent pathways of growth arrest and programmed cell death.
